(Allergan plc)

	AGN latest price $238.0577 (1.34%) ($231.6586 - $238.8780) on Wed. Oct. 8, 2014.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.27% (three month average)
RSI	59
Latest Price	$238.0577(1.34%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.7% a day on average for past five trading days.
Weekly Trend	AGN advances 0.5% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(56%)    XBI(47%)    SPY(44%)    VT(43%)    QQQ(42%)
Factors Impacting AGN price	AGN will decline at least -0.635% in a week (0% probabilities).   VIXM(-33%)    TLT(-18%)    SHY(-8%)    IGOV(-6%)    GLD(-5%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.635% (StdDev 1.27%)
Hourly BBV	0 ()
Intraday Trend	1.3%

5 Day Moving Average	$234.74(1.41%)
10 Day Moving Average	$234.5(1.52%)
20 Day Moving Average	$232.37(2.45%)
To recent high	-0.5%
To recent low	21.7%
Market Cap	$78.488b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed